Answered

Find the best solutions to your problems with the help of IDNLearn.com's expert users. Discover the information you need from our experienced professionals who provide accurate and reliable answers to all your questions.

Which of the following is true regarding immune-related adverse events associated with the use of immune checkpoint inhibitor therapy?

A. These reactions are highly correlated with the second dose of checkpoint inhibitor therapy.
B. These reactions may have delayed onset and may be inflammatory or autoimmune in nature.
C. Corticosteroids should only be given for grade 3 toxicities.
D. These reactions are less likely to occur when checkpoint inhibitor therapy is combined with targeted therapy.

Sagot :

GinnyAnsweridn

Final answer:

Immune-related adverse events with immune checkpoint inhibitors can have delayed onset and may be inflammatory/autoimmune. Corticosteroids may be necessary for grade 3 toxicities, and the reactions are not less likely with combined therapy.


Explanation:

Regarding immune-related adverse events associated with the use of immune checkpoint inhibitor therapy:

  1. These reactions may have delayed onset and may be inflammatory or autoimmune in nature.
  2. Corticosteroids may need to be given for grade 3 or higher toxicities.
  3. These reactions are not less likely to occur when checkpoint inhibitor therapy is combined with targeted therapy.

Learn more about Immune-related adverse events with immune checkpoint inhibitors here:

https://brainly.com/question/28408407


We appreciate your presence here. Keep sharing knowledge and helping others find the answers they need. This community is the perfect place to learn together. For clear and precise answers, choose IDNLearn.com. Thanks for stopping by, and come back soon for more valuable insights.